Epigral Limited
Epigral Limited (EPIGRAL) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
epigral.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 478 Cr | 472 Cr | 525 Cr | 651 Cr | 626 Cr | 645 Cr | 628 Cr | 607 Cr | 587 Cr | 597 Cr | 736 Cr | 705 Cr |
| Operating expenses (approx.) | 370 Cr | 349 Cr | 369 Cr | 475 Cr | 448 Cr | 463 Cr | 454 Cr | 443 Cr | 455 Cr | 494 Cr | 568 Cr | 526 Cr |
| EBITDA | 108 Cr | 123 Cr | 155 Cr | 176 Cr | 178 Cr | 183 Cr | 173 Cr | 163 Cr | 132 Cr | 103 Cr | 169 Cr | 179 Cr |
| OPM % | 22.6% | 26.0% | 29.6% | 27.1% | 28.5% | 28.3% | 27.6% | 26.9% | 22.5% | 17.2% | 22.9% | 25.4% |
| Other income | 1 Cr | 2 Cr | 2 Cr | 2 Cr | 6 Cr | 4 Cr | 3 Cr | 8 Cr | 2 Cr | 6 Cr | -0.57 Cr | 4 Cr |
| Interest | 21 Cr | 20 Cr | 14 Cr | 14 Cr | 27 Cr | -0.07 Cr | 12 Cr | 23 Cr | 22 Cr | 11 Cr | 16 Cr | 7 Cr |
| Depreciation | 32 Cr | 31 Cr | 30 Cr | 33 Cr | 32 Cr | 33 Cr | 34 Cr | 42 Cr | 42 Cr | 43 Cr | 42 Cr | 43 Cr |
| Profit before tax | 56 Cr | 74 Cr | 113 Cr | 131 Cr | 125 Cr | 154 Cr | 131 Cr | 107 Cr | 70 Cr | 55 Cr | 110 Cr | 134 Cr |
| Tax % | 32.1% | 33.6% | 31.9% | 34.4% | 35.1% | 32.5% | 33.8% | -50.2% | 26.5% | 28.3% | 26.1% | 25.4% |
| Net profit | 38 Cr | 49 Cr | 77 Cr | 86 Cr | 81 Cr | 104 Cr | 87 Cr | 161 Cr | 51 Cr | 39 Cr | 81 Cr | 100 Cr |
| EPS (₹) | ₹9.14 | ₹11.81 | ₹18.60 | ₹20.67 | ₹19.57 | ₹24.25 | ₹20.14 | ₹37.25 | ₹11.87 | ₹9.07 | ₹18.76 | ₹23.12 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| Sales | 1,551 Cr | 2,188 Cr | 1,929 Cr | 2,550 Cr | 2,527 Cr | Sign in for TTM |
| Operating expenses (approx.) | 1,041 Cr | 1,499 Cr | 1,448 Cr | 1,839 Cr | 1,960 Cr | Sign in for TTM |
| EBITDA | 509 Cr | 689 Cr | 481 Cr | 711 Cr | 567 Cr | Sign in for TTM |
| OPM % | 32.9% | 31.5% | 24.9% | 27.9% | 22.4% | Sign in for TTM |
| Other income | 4 Cr | 8 Cr | 7 Cr | 15 Cr | 15 Cr | Sign in for TTM |
| Interest | 44 Cr | 66 Cr | 73 Cr | 53 Cr | 72 Cr | Sign in for TTM |
| Depreciation | 86 Cr | 109 Cr | 124 Cr | 133 Cr | 168 Cr | Sign in for TTM |
| Profit before tax | 383 Cr | 522 Cr | 291 Cr | 541 Cr | 341 Cr | Sign in for TTM |
| Tax % | 34.1% | 32.4% | 32.6% | 33.9% | 2.6% | Sign in for TTM |
| Net profit | 253 Cr | 353 Cr | 196 Cr | 358 Cr | 332 Cr | Sign in for TTM |
| EPS (₹) | ₹60.84 | ₹85.03 | ₹47.13 | ₹84.68 | ₹76.95 | Sign in for TTM |
| Dividend payout % | 0.0% | 6.9% | 5.3% | 8.8% | 5.5% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity capital | 42 Cr | 42 Cr | 42 Cr | 43 Cr | 43 Cr |
| Reserves | 684 Cr | 1,028 Cr | 1,213 Cr | 1,861 Cr | 2,178 Cr |
| Borrowings | 989 Cr | 876 Cr | 963 Cr | 585 Cr | 563 Cr |
| Other liabilities | 408 Cr | 487 Cr | 578 Cr | 663 Cr | 721 Cr |
| Total liabilities | 2,124 Cr | 2,432 Cr | 2,794 Cr | 3,152 Cr | 3,505 Cr |
| Fixed assets (net) | 1,039 Cr | 1,779 Cr | 1,745 Cr | 2,219 Cr | 2,102 Cr |
| CWIP | 589 Cr | 158 Cr | 483 Cr | 64 Cr | 451 Cr |
| Investments | 0 Cr | 21 Cr | 21 Cr | 98 Cr | 23 Cr |
| Loans & advances | 0.23 Cr | 0.14 Cr | 0.48 Cr | 0.39 Cr | 0.35 Cr |
| Inventories | 154 Cr | 212 Cr | 263 Cr | 388 Cr | 349 Cr |
| Trade receivables | 256 Cr | 166 Cr | 179 Cr | 232 Cr | 417 Cr |
| Cash & bank | 25 Cr | 14 Cr | 3 Cr | 19 Cr | 5 Cr |
| Other assets | 59 Cr | 82 Cr | 101 Cr | 132 Cr | 159 Cr |
| Total assets | 2,124 Cr | 2,432 Cr | 2,794 Cr | 3,152 Cr | 3,505 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Cash from operating activity | 284 Cr | 626 Cr | 398 Cr | 441 Cr | 436 Cr |
| Cash from investing | -455 Cr | -437 Cr | -401 Cr | -262 Cr | -355 Cr |
| Cash from financing | 195 Cr | -200 Cr | -8 Cr | -164 Cr | -94 Cr |
| Net cash flow | 24 Cr | -11 Cr | -11 Cr | 15 Cr | -14 Cr |
| Free cash flow (OCF − Capex) | -172 Cr | 210 Cr | -0.79 Cr | 246 Cr | 41 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| ROCE % | 58.9% | 30.2% | 16.4% | 23.9% | 14.8% |
| ROE % | 34.8% | 33.0% | 15.6% | 18.8% | 14.9% |
| Debtor days | 60 | 28 | 34 | 33 | 60 |
| Inventory days | 74 | 64 | 90 | 107 | 85 |
| Days payable | 42 | 33 | 56 | 51 | 63 |
| Cash conversion cycle | 92 | 58 | 67 | 89 | 82 |
| Debt / equity | 1.36 | 0.82 | 0.77 | 0.31 | 0.25 |
| Current ratio | 0.84 | 0.65 | 0.64 | 1.57 | 1.16 |
| Net debt / EBITDA | 0.00 | 1.25 | 1.99 | 0.80 | 0.98 |
Compare with peers
Loading peers…